(Q31113119)

English

Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

0 references

Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

LHRH-agonists in Early Breast Cancer Overview group

1

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

J Cuzick

2

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

L Ambroisine

3

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

N Davidson

4

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

R Jakesz

5

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

M Kaufmann

6

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

M Regan

7

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

R Sainsbury

8

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

language of work or name

0 references

publication date

1 May 2007

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

369

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

9574

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

1711-1723

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960778-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960778-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival analyses from the ZEBRA study. goserelin (Zoladex) versus CMF in premenopausal women with node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960778-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer--Austrian

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960778-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant goserelin in pre-menopausal patients with early breast cancer: Results from the ZIPP study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960778-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960778-8

7 January 2021

based on heuristic

inferred from DOI database lookup

CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: a randomised trial (GABG trial IV-A-93)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960778-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Complete hormonal blockade versus epirubicin-based chemotherapy in premenopausal, one to three node-positive, and hormone-receptor positive, early breast cancer patients: 7-year follow-up results of French Adjuvant Study Group 06 randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960778-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of adjuvant ovarian suppression in 926 premenopausal patients with early breast cancer treated with adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960778-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophosphamide, methotrexate, and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-/perimenopausal breast cancer patients: results of the Italian Breast Cancer Adjuvant Study Group 02 r

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960778-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960778-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960778-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of chemotherapy with or without buserelin on serum hormone levels in premenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960778-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960778-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Ovarian ablation or suppression in premenopausal early breast cancer: results from the international adjuvant breast cancer ovarian ablation or suppression randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960778-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life in goserelin-treated versus cyclophosphamide + methotrexate + fluorouracil-treated premenopausal and perimenopausal patients with node-positive, early breast cancer: the Zoladex Early Breast Cancer Research Association Trialists Grou

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960778-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960778-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(07)60778-8

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31113119&oldid=1611042510"